Early Phase Cancer Immunotherapy
Produktform: Buch / Einband - flex.(Paperback)
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.weiterlesen
Dieser Artikel gehört zu den folgenden Serien
160,49 € inkl. MwSt.
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage
zurück